Depression and Driving (NCT05446805)

🧪 Interventions in This Study

• F 18 AV-1451 (Flortaucipir) (DRUG)
• [11C]-Pittsburgh Compound B ([11C]PiB) (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Washington University School of Medicine — St Louis, Missouri

📞 Contact the Study Coordinator

Phone: (314) 273-3573

Email: kaylin.james@wustl.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Depression

• Neural Circuit Biomarkers of Transcranial Magnetic Stimulation Study — Stanford, California
• Meditation Accelerated Brain Stimulation for Depression — San Diego, California
• A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers — Houston, Texas
• EEG Biomarker Study for Participants in the Neurolief "MOOD" Trial — Providence, Rhode Island
• Using rTMS to Treat Depression — Miami, Florida
• Integrating Ketamine Effects on Neuronal Molecular Signatures and the Brain Functional and Structural Connectome — Boston, Massachusetts

Explore by condition: All Depression clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.